Cultural diversity in physical diseases among patients with mental illnesses

Australian and New Zealand Journal of Psychiatry

Volumn 47, Issue 3, 2013, Pages 250-258

  Larsen, Jens I ^a   Andersen, Ulla A ^b   Becker, Thomas ^c   Bickel, Graziella G ^d   Bork, Bernhard ^e   Cordes, Joachim ^f   Frasch, Karel ^c   Jacobsen, Bent A ^a   Jensen, Signe O Wallenstein ^a   Kilian, Reinhold ^c   Lauber, Christoph ^g   Mogensen, Birthe ^h   Nielsen, Jørgen A ⁱ   Rössler, Wulf ^g   Tsuchiya, Kenji J ^j   Uwakwe, Richard ^k   Munk Jørgensen, Povl ⁱ  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY HOSPITAL ULM   (Germany)

^d Psychiatric Hospital   (Switzerland)

^e Psychiatric Hospital   (Denmark)

^f Department of Orthopedic Surgery   (Germany)

^g UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

^h Psychiatric Hospital Slagelse   (Denmark)

ⁱ AARHUS UNIVERSITY HOSPITAL   (Denmark)

^j HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^k NNAMDI AZIKIWE UNIVERSITY   (Nigeria)

more..

Author keywords

Cardiovascular disease; Diabetes; Mood disorders; Obesity; Physical health; Schizophrenia; Transcultural psychiatry

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; COMORBIDITY; CULTURAL ANTHROPOLOGY; DENMARK; DIABETES MELLITUS; FEMALE; GERMANY; HUMAN; ICD-10; INCIDENCE; JAPAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MORBIDITY; NIGERIA; OBESITY; PHYSICAL DISEASE; PREVALENCE; SWITZERLAND;

ADULT; CARDIOVASCULAR DISEASES; COMORBIDITY; CROSS-CULTURAL COMPARISON; DENMARK; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; DIABETES MELLITUS; FEMALE; GERMANY; HUMANS; INCIDENCE; JAPAN; MALE; MIDDLE AGED; MOOD DISORDERS; NIGERIA; OBESITY; PREVALENCE; SCHIZOPHRENIA; SWITZERLAND;

EID: 84880544877     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1177/0004867412463614     Document Type: Article

References (32)

1. Bhugra D and Becker MA (2005) Migration, cultural bereavement and cultural identity. World Psychiatry 4: 18-24.
2. Bhugra D, Gupta S, Bhui K, et al. (2011) WPA Guidance of mental health and mental health care in immigrants. World Psychiatry 10: 2-10.
3. Correll CU and Nielsen J (2010) Antipsychotic-associated all-cause and cardiac mortality: What should we worry about and how should the risk be assessed? Acta Psychiatrica Scandinavica 122: 341-344.
4. Craig R and Mindell J (eds) (2008) Health Survey for England 2006, Volume 1. Cardiovascular disease and risk factors in adults. Joint Health Surveys Unit of the National Centre for Social Research (NatCen) and the Department of Epidemiology and Public Health at the Royal Free and University College Medical School. Available at: www.ic.nhs.uk/pubs/HSE06CVDandriskfactors (accessed 14 - 16 May 2012). Leeds, UK: The Information Centre .
5. De Hert M, Correll CU, Bates J, et al. (2011a) Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry 10: 52-77.
6. De Hert M, Detraux J, van Winkel R, et al. (2011b) Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nature Reviews. Endocrinology 8: 114-126.
7. De Hert M, Dekker JM, Wood D, et al. (2009) Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). European Psychiatry 24: 412-424.
8. De Hert M, Schreurs V and Vancampfort D (2009) Metabolic syndrome in people with Schizophrenia: A review. World Psychiatry 8: 15-22.
9. Dixon L, Postrado L, Delahanty J, et al. (1999) The association of medical comorbidity in schizophrenia with poor physical and mental health. Journal of Nervous and Mental Disease 187: 496-502.
10. Fleischhacker WW, Cetkovich-Bakmas M, De Hert M, et al. (2008) Comorbid somatic illness in patients with severe mental disorders: Clinical, policy, and research challenges. Journal of Clinical Psychiatry 69: 514-519.
11. Geli M, Carcia-Toro M, Vives M, et al. (2011) Medical cormorbidity in recurrent versus first-episode depressive patients. Acta Psychiatrica Scandinavica 123: 220-227.
12. Gillum RF (1996) The epidemiology of cardiovascular disease in black Americans. New England Journal of Medicine 335: 1597-1599.
13. Goldman LS (1999) Medical illness in patients with schizophrenia. Journal of Clinical Psychiatry 60: 10-15.
14. Harris EC and Barraclough C (1998) Excess mortality of mental disorder. British Journal of Psychiatry 173: 11-53.
15. Janszky I, Ahlbom L, Hallqvist J, et al. (2007) Hospitalization for depression is associated with an increased risk for myocardial infarction not explained by lifestyle, lipids, coagulation, and inflammation. The SHEEP study. Biological Psychiatry 62: 25-32.
16. Jeste DV, Gladsjo JA, Lindamer LA, et al. (1996) Medical comorbidity in schizophrenia. Schizophrenia Bulletin 22: 413-430.
17. Lambert TJR, Velakoulis D and Pantelis C (1996) Medical comorbidity in schizophrenia. Medical Journal of Australia 178: 67-70.
18. Leucht S, Burkard T, Henderson J, et al. (2007) Physical illness and schizophrenia: A review of the literature. Acta Psychiatrica Scandinavica 116: 317-333.
19. Mazzoncini R, Donoghue K, Hart J, et al. (2010) Illicit substance use and its correlates in first episode psychosis. Acta Psychiatrica Scandinavica 121: 351-358.
20. Mirzaei M, Truswell AS, Taylor R, et al. (2009) Coronary heart disease epidemics: Not all the same. Heart 95: 740-746.
21. Nippon DATA80 Research Group (2006) Risk assessment for death from cardiovascular disease based on a 19-year follow up study of a Japanese representative population. Circulation Journal 70: 1249-1255.
22. Rosenberg SD, Goodman LA, Osher FC, et al. (2001) Prevalence of HIV, hepatitis B and hepatitis C in people with severe mental illness. American Journal of Public Health 91: 31-37.
23. Saha S, Chant D and McGrath J (2007) A systematic review of mortality in schizophrenia. Is the differential mortality gap worsening over time? Archives of General Psychiatry 64: 1123-1131.
24. Saito I, Folsom AR, Aono H, et al. (2000) Comparison of fatal coronary heart disease occurrence based on population surveys in Japan and the USA. International Journal of Epidemiology 29: 837-844.
25. Simpson JC and Tsuang MT (1996) Mortality among patients with schizophrenia. Schizophrenia Bulletin 22: 485-499.
26. Stapelberg NJC, Neumann DL, Shum DH, et al. (2011) A topographical map of the causal network of mechanisms underlying the relationship between major depressive disorder and coronary heart disease. Australian and New Zealand Journal of Psychiatry 45: 351-369.
27. Taylor V and MacQueen G (2006) Associations between bipolar disorder and metabolic syndrome: A review. Journal of Clinical Psychiatry 67: 1034-1041.
28. Van Reedt Dortland AKB, Giltay EJ, van Veen T, et al. (2010) Metabolic syndrome abnormalities are associated with severity of anxiety and depression and with tricyclic antidepressant use. Acta Psychiatrica Scandinavica 122: 30-39.
29. Von Hausswolff-Juhlin Y, Bjartneit M, Lindström E, et al. (2009) Schizophrenia and physical health problems. Acta Psychiatrica Scandinavica 119(suppl 428): 15-21.
30. Yano K, Rhoads GG, Kagan A, et al. (1978) Dietary intake and the risk of coronary heart disease in Japanese men living in Hawaii. American Journal of Clinical Nutrition 31: 1270-1279.
31. Ücok A and Gaebel W (2008) Side effects of atypical antipsychotics: A brief overview. World Psychiatry 7: 58-62.
32. World Health Organization (1992) The ICD-10 Classification of Mental and Behavioural Disorders: Clinical descriptions and diagnostic guidelines. Geneva: World Health Organization.